Overview

Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
An open-label, single centre, randomised, cross-over study to examine the effect of ulimorelin on the pharmacokinetics of midazolam after repeat dose administration of ulimorelin in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Norgine
Treatments:
Midazolam